These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 25624880

  • 1. Targeted therapy with propranolol and metronomic chemotherapy combination: sustained complete response of a relapsing metastatic angiosarcoma.
    Banavali S, Pasquier E, Andre N.
    Ecancermedicalscience; 2015; 9():499. PubMed ID: 25624880
    [Abstract] [Full Text] [Related]

  • 2. Effective Management of Advanced Angiosarcoma by the Synergistic Combination of Propranolol and Vinblastine-based Metronomic Chemotherapy: A Bench to Bedside Study.
    Pasquier E, André N, Street J, Chougule A, Rekhi B, Ghosh J, Philip DSJ, Meurer M, MacKenzie KL, Kavallaris M, Banavali SD.
    EBioMedicine; 2016 Apr; 6():87-95. PubMed ID: 27211551
    [Abstract] [Full Text] [Related]

  • 3. Preliminary evaluation of children treated with metronomic chemotherapy and valproic acid in a low-income country: Metro-Mali-02.
    Traore F, Togo B, Pasquier E, Dembélé A, André N.
    Indian J Cancer; 2013 Apr; 50(3):250-3. PubMed ID: 24061467
    [Abstract] [Full Text] [Related]

  • 4. Sustained Complete Response to Metronomic Chemotherapy in a Child with Refractory Atypical Teratoid Rhabdoid Tumor: A Case Report.
    Berland M, Padovani L, Rome A, Pech-Gourg G, Figarella-Branger D, André N.
    Front Pharmacol; 2017 Apr; 8():792. PubMed ID: 29163174
    [Abstract] [Full Text] [Related]

  • 5. Metronomic Chemotherapy for Children in Low- and Middle-Income Countries: Survey of Current Practices and Opinions of Pediatric Oncologists.
    Revon-Rivière G, Banavali S, Heississen L, Gomez Garcia W, Abdolkarimi B, Vaithilingum M, Li CK, Leung PC, Malik P, Pasquier E, Epelman S, Chantada G, André N.
    J Glob Oncol; 2019 Jul; 5():1-8. PubMed ID: 31260397
    [Abstract] [Full Text] [Related]

  • 6. Metastatic Primary Angiosarcoma of the Breast: Can We Tame It the Metronomic Way.
    Pramanik R, Gogia A, Malik PS, Gogi R.
    Indian J Med Paediatr Oncol; 2017 Jul; 38(2):228-231. PubMed ID: 28900339
    [Abstract] [Full Text] [Related]

  • 7. Lessons from the Fourth Metronomic and Anti-angiogenic Therapy Meeting, 24-25 June 2014, Milan.
    Bouche G, André N, Banavali S, Berthold F, Berruti A, Bocci G, Brandi G, Cavallaro U, Cinieri S, Colleoni M, Curigliano G, Di Desidero T, Eniu A, Fazio N, Kerbel R, Hutchinson L, Ledzewicz U, Munzone E, Pasquier E, Graciela Scharovsky O, Shaked Y, Stěrba J, Villalba M, Bertolini F.
    Ecancermedicalscience; 2014 Jul; 8():463. PubMed ID: 25228919
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Highlights from the 1st Latin American meeting on metronomic chemotherapy and drug repositioning in oncology, 27-28 May, 2016, Rosario, Argentina.
    Rosé A, André N, Rozados VR, Mainetti LE, Menacho Márquez M, Rico MJ, Schaiquevich P, Villarroel M, Gregianin L, Graupera JM, García WG, Epelman S, Alasino C, Alonso D, Chantada G, Scharovsky OG.
    Ecancermedicalscience; 2016 Jul; 10():672. PubMed ID: 27610198
    [Abstract] [Full Text] [Related]

  • 10. Regression of primary cardiac angiosarcoma and metastatic nodules following propranolol as a single agent treatment.
    Galván DC, Ayyappan AP, Bryan BA.
    Oncoscience; 2018 Sep; 5(9-10):264-268. PubMed ID: 30460329
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Next generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, Mumbai.
    Pantziarka P, Hutchinson L, André N, Benzekry S, Bertolini F, Bhattacharjee A, Chiplunkar S, Duda DG, Gota V, Gupta S, Joshi A, Kannan S, Kerbel R, Kieran M, Palazzo A, Parikh A, Pasquier E, Patil V, Prabhash K, Shaked Y, Sholler GS, Sterba J, Waxman DJ, Banavali S.
    Ecancermedicalscience; 2016 Sep; 10():689. PubMed ID: 27994645
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Pertuzumab and trastuzumab with or without metronomic chemotherapy for older patients with HER2-positive metastatic breast cancer (EORTC 75111-10114): an open-label, randomised, phase 2 trial from the Elderly Task Force/Breast Cancer Group.
    Wildiers H, Tryfonidis K, Dal Lago L, Vuylsteke P, Curigliano G, Waters S, Brouwers B, Altintas S, Touati N, Cardoso F, Brain E.
    Lancet Oncol; 2018 Mar; 19(3):323-336. PubMed ID: 29433963
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Non-selective beta blockers inhibit angiosarcoma cell viability and increase progression free- and overall-survival in patients diagnosed with metastatic angiosarcoma.
    Amaya CN, Perkins M, Belmont A, Herrera C, Nasrazadani A, Vargas A, Khayou T, Montoya A, Ballou Y, Galvan D, Rivas A, Rains S, Patel L, Ortega V, Lopez C, Chow W, Dickerson EB, Bryan BA.
    Oncoscience; 2018 Mar; 5(3-4):109-119. PubMed ID: 29854879
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.